Infectious Disease Research in Munich
The quality and integration of research in the area of Infectious Diseases and Immunology in Munich is well documented by existing research networks.
Members of ZIMM have initiated these research networks or have made significant contributions to them. The ZIMM research infrastructure has arisen from these pre-existing structures.
Through the involvement of institutes involved in basic research as well as direct patient care, access to specialized equipment and facilities is enhanced. ZIMM also provides a balanced management structure for the definition of focal points – both technical and methodical – in infectious disease research and carries out joint projects under national and international sponsorship.
- SFB 455 Viral Functions and Immunomodulation (LMU / HMGU / TUM)
- SFB 576 Facultative Microbial Pathogenesis and Innate Immunity (TUM / LMU)
- SFB 456 Target Structures for Selective Tumor Interventions (TUM / LMU)
- SFB 571 Autoimmune Reactions: from Manifestations to Mechanisms to Therapy (LMU / TUM)
- SFB 800 T-Cell Plasticity in Context
- SFB/TR 22 Allergic Immune Response of the Lungs (LMU / TUM),
- SFB/TR 36 Fundamentals and Applications of Adoptive T-Cell Therapy (HMGU / TUM / LMU),
- FOR 535 Xenotransplantation (LMU)
- GRK 1202 Oligonucleotides in Cell Biology and Therapy (LMU)
- HAIT Helmholtz Alliance Immunotherapy (HMGU / TUM / LMU)
- BMBF Spitzencluster –Clusters of Excellence m4 Personalized Medication Development (TUM / LMU / HMGU)
- BMBF/EU Networks: National Genomic Research Network, Pathogenomics, System Biology, EuroPathoGenoMik, Diagnostics (PanACEA (Tb), HOPE (HBV)), Vaccine Development (AVIP, AfreVacc, TaMoVac), Infectious Disease Determinants (IDEA, ECHO) (LMU / HMGU / TUM)